ARE establishment stage | Category | ERY-specific | Common | MEG-specific | |||
---|---|---|---|---|---|---|---|
LSK | AREs | 1112 | 5926 | 5385 | |||
No. genes assigned as ARE targets | 1118 | 7963 | 4462 | ||||
No. genes expressed | 940 | 84% | 7459 | 93% | 3965 | 89% | |
CMP | AREs | 1727 | 5967 | 6068 | |||
No. genes assigned as ARE targets | 1606 | 7982 | 4767 | ||||
No. genes expressed | 1294 | 81% | 7415 | 94% | 4083 | 86% | |
Committed progenitor | AREs | 2054 | 5975 | 6286 | |||
No. genes assigned as ARE targets | 1829 | 7987 | 4848 | ||||
No. genes expressed | 1443 | 79% | 7266 | 90% | 4238 | 87% | |
Terminally differentiated cell | AREs | 2098 | 5989 | 6386 | |||
No. genes assigned as ARE targets | 1853 | 7998 | 4890 | ||||
No. genes expressed | 1527 | 82% | 7464 | 93% | 4341 | 89% |